Shots: The P-III UNIFI study involves assessing the safety & efficacy of Stelara (90mg, q8w/q12w) as induction and maintenance therapy vs PBO in 588 patients with UC with inadequate response […]readmore
Tags : Active Ulcerative Colitis
Shots: The approval is based on a P-III True North trial assess Zeposia (0.92 mg) vs PBO in an adult with mod. to sev. active UC The trial met its […]readmore
Shots: The submission is based on P-III UNIFI study (had two part one induction and second maintenance) results assessing Stelara vs PBO (130 mg, 6 mg/kg) in 961 patients in […]readmore